Oct 3 (Reuters) - Bubs Australia (BUB) on Monday said that it had lodged a letter of intent with the U.S. Food and Drug Administration (FDA) for permanent market access in the United States to October 2025 and beyond.
The infant formula maker said the FDA intends to issue a letter of acknowledgement in response to the letter of intent.
News: BUB Bubs Australia seeks permanent market access from U.S. FDA
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $107.1M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.3¢ | 12.0¢ | $113.0K | 941.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 300859 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 2334794 | 43 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| BUB (ASX) Chart |